ACTIVE

ULTRAZONIC

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-7,5 k €

-109.7% YoY

Gross margin

273,3 k €

-6.2% YoY

Equity

974,4 k €

-0.8% YoY

Workforce

4,0 ETP

+21.2% YoY

What does ULTRAZONIC do?

ULTRAZONIC is a Public limited company incorporated in 2015. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Zandhoven. It employs on average 4,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0643.900.747

Incorporation

07/12/2015

Legal form

Public limited company

Registered office

Boutersemdreef 26
2240 Zandhoven · FlandreSee on map

Contributed capital

1 630 000,00 €

Latest accounts

31/12/2025

Average workforce

4,0 ETP

Activities (NACE)

32500Manufacture of medical and dental instruments and supplies· main 32500Manufacture of medical and dental instruments and supplies 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods

Joint committees (2)

Signals

Solid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 9 financial years

	2025		2024		2023		2022		2021		2020		2019		2017		2016
Income statement
Gross margin	273,3 k €	-6.2%	291,5 k €	-54.5%	640,9 k €	+473%	-172 k €	-161%	279,9 k €	-31.5%	408,6 k €	+1008%	-45 k €	+10.7%	-50,4 k €	-1066%	5,2 k €
EBITDA	17,9 k €	-85.1%	120,2 k €	-70.4%	406,5 k €	+202%	-397,1 k €	-676%	69 k €	-69.8%	228,7 k €	+205%	-218,3 k €	-514%	-35,6 k €	-1202%	3,2 k €
Operating result	5,3 k €	-95.2%	108,5 k €	-71.7%	383,5 k €	+190%	-424,7 k €	-1250%	36,9 k €	-81.1%	195,7 k €	+177%	-252,5 k €	-338%	-57,6 k €	-6562%	891,3 €
Net result	-7,5 k €	-110%	77,9 k €	-78.0%	353,5 k €	+181%	-438,6 k €	-1969%	23,5 k €	-83.6%	143,1 k €	+149%	-292,6 k €	-374%	-61,7 k €	-29554%	209,4 €
Balance sheet
Equity	974,4 k €	-0.8%	981,9 k €	+60.9%	610,4 k €	+138%	256,9 k €	-63.1%	695,5 k €	+3.5%	672 k €	+77.3%	378,9 k €	+575%	56,1 k €	+776%	6,4 k €
Total assets	2,1 M €	+23.5%	1,7 M €	-0.1%	1,7 M €	-39.6%	2,8 M €	+20.9%	2,4 M €	-31.3%	3,4 M €	+384%	707,5 k €	+40.7%	502,9 k €	+360%	109,3 k €
Cash	12,5 k €	-63.3%	34 k €	+3510%	941,9 €	-96.1%	24,1 k €	-93.8%	385,4 k €	-49.0%	756 k €	+1670%	42,7 k €	-84.4%	273,1 k €	+3431%	7,7 k €
Debts	1,1 M €	+56.0%	728,1 k €	-34.3%	1,1 M €	-57.2%	2,6 M €	+56.1%	1,7 M €	-39.8%	2,8 M €	+738%	328,6 k €	-26.5%	446,8 k €	+339%	101,8 k €
Other
Workforce	4,0 ETP	+21.2%	3,3 ETP	-15.4%	3,9 ETP	+2.6%	3,8 ETP	0.0%	3,8 ETP	+8.6%	3,5 ETP	+2.9%	3,4 ETP		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 8 ended

Active mandates

Paul Sucaet

Director · since 21 juin 2019

Active

Nancy Steenbakkers

Director · since 20 octobre 2017

Active

Serge Wellens

Director · since 20 octobre 2017

Active

Ended mandates

Nancy Steenbakkers

Managing director · since 20 octobre 2017

Ended

Stephan Huybrechts

Director · since 20 octobre 2017

Ended

XIPHIAS

Director · since 20 octobre 2017 · 0890.616.584

Represented by Joost Boel

Ended

Nancy Steenbakkers

Manager · since 03 décembre 2015

Ended

At this address

Other companies at this address

Company	CBE no.
Quimedic● Active	1012.461.353
Zonic● Active	0737.367.769
Z-PROJECTS● Active	0808.009.307

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	27/07/2026	18/08/2025	30/07/2024	27/07/2023	29/07/2022	05/08/2021
General meeting	16/06/2026	18/07/2025	10/07/2024	16/06/2023	29/06/2022	03/08/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

10 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	16/06/2026	27/07/2026	Dutch	PDF
Abridged model	31/12/2024	18/07/2025	18/08/2025	Dutch	PDF
Abridged model	31/12/2023	10/07/2024	30/07/2024	Dutch	PDF
Abridged model	31/12/2022	16/06/2023	27/07/2023	Dutch	PDF
Abridged model	31/12/2021	29/06/2022	29/07/2022	Dutch	PDF
Abridged model	31/12/2020	03/08/2021	05/08/2021	Dutch	PDF
Abridged model	31/12/2019	25/08/2020	23/10/2020	Dutch	PDF
Abridged model	31/12/2018	11/06/2019	16/07/2019	Dutch	PDF
Abridged model	31/12/2017	28/06/2018	27/07/2018	Dutch	PDF
Abridged model	31/12/2016	26/09/2017	03/10/2017	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 8 ended

Active mandates

Paul Sucaet

Director · since 21 juin 2019

Active

Nancy Steenbakkers

Director · since 20 octobre 2017

Active

Serge Wellens

Director · since 20 octobre 2017

Active

Ended mandates

Nancy Steenbakkers

Managing director · since 20 octobre 2017

Ended

Stephan Huybrechts

Director · since 20 octobre 2017

Ended

XIPHIAS

Director · since 20 octobre 2017 · 0890.616.584

Represented by Joost Boel

Ended

Nancy Steenbakkers

Manager · since 03 décembre 2015

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates18/03/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/10/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/12/2018
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares08/02/2018
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates07/11/2017
MAATSCHAPPELIJKE ZETEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares01/02/2017
KAPITAAL - AANDELEN
PDF
Mandates19/01/2017
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates31/10/2016
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-7,5 k €↓
2024
Annual accounts 202477,9 k €↓
2023
Annual accounts 2023353,5 k €↑
2022
Annual accounts 2022-438,6 k €↓
2021
Annual accounts 202123,5 k €↓
2020
Annual accounts 2020143,1 k €↑
2019
Annual accounts 2019-292,6 k €↓
2017
Annual accounts 2017-61,7 k €↓
2016
Annual accounts 2016209,4 €
07/12/2015
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

ULTRAZONIC

Overview

What does ULTRAZONIC do?

Trend over 9 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline